These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 11929132)

  • 21. Crystal structure of interleukin-19 defines a new subfamily of helical cytokines.
    Chang C; Magracheva E; Kozlov S; Fong S; Tobin G; Kotenko S; Wlodawer A; Zdanov A
    J Biol Chem; 2003 Jan; 278(5):3308-13. PubMed ID: 12403790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-19 induces production of IL-6 and TNF-alpha and results in cell apoptosis through TNF-alpha.
    Liao YC; Liang WG; Chen FW; Hsu JH; Yang JJ; Chang MS
    J Immunol; 2002 Oct; 169(8):4288-97. PubMed ID: 12370360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psoriasis and other Th17-mediated skin diseases.
    Tokura Y; Mori T; Hino R
    J UOEH; 2010 Dec; 32(4):317-28. PubMed ID: 21226422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystal structure of the IL-10/IL-10R1 complex reveals a shared receptor binding site.
    Josephson K; Logsdon NJ; Walter MR
    Immunity; 2001 Jul; 15(1):35-46. PubMed ID: 11485736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-22 and its crystal structure.
    Nagem RA; Ferreira Júnior JR; Dumoutier L; Renauld JC; Polikarpov I
    Vitam Horm; 2006; 74():77-103. PubMed ID: 17027512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-10 suppression of myeloid cell activation--a continuing puzzle.
    Williams LM; Ricchetti G; Sarma U; Smallie T; Foxwell BM
    Immunology; 2004 Nov; 113(3):281-92. PubMed ID: 15500614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-22 forms dimers that are recognized by two interleukin-22R1 receptor chains.
    de Oliveira Neto M; Ferreira JR; Colau D; Fischer H; Nascimento AS; Craievich AF; Dumoutier L; Renauld JC; Polikarpov I
    Biophys J; 2008 Mar; 94(5):1754-65. PubMed ID: 18024507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crystal structure of the IL-22/IL-22R1 complex and its implications for the IL-22 signaling mechanism.
    Bleicher L; de Moura PR; Watanabe L; Colau D; Dumoutier L; Renauld JC; Polikarpov I
    FEBS Lett; 2008 Sep; 582(20):2985-92. PubMed ID: 18675809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure of interleukin-10/interleukin-10R1 complex: a paradigm for class 2 cytokine activation.
    Walter MR
    Immunol Res; 2002; 26(1-3):303-8. PubMed ID: 12403368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cutting edge: IL-26 signals through a novel receptor complex composed of IL-20 receptor 1 and IL-10 receptor 2.
    Sheikh F; Baurin VV; Lewis-Antes A; Shah NK; Smirnov SV; Anantha S; Dickensheets H; Dumoutier L; Renauld JC; Zdanov A; Donnelly RP; Kotenko SV
    J Immunol; 2004 Feb; 172(4):2006-10. PubMed ID: 14764663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukins 19, 20, and 24 signal through two distinct receptor complexes. Differences in receptor-ligand interactions mediate unique biological functions.
    Parrish-Novak J; Xu W; Brender T; Yao L; Jones C; West J; Brandt C; Jelinek L; Madden K; McKernan PA; Foster DC; Jaspers S; Chandrasekher YA
    J Biol Chem; 2002 Dec; 277(49):47517-23. PubMed ID: 12351624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-21 is an immune activator that also mediates suppression via IL-10.
    Spolski R; Leonard WJ
    Crit Rev Immunol; 2010; 30(6):559-70. PubMed ID: 21175418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure and mechanism of receptor sharing by the IL-10R2 common chain.
    Yoon SI; Jones BC; Logsdon NJ; Harris BD; Deshpande A; Radaeva S; Halloran BA; Gao B; Walter MR
    Structure; 2010 May; 18(5):638-48. PubMed ID: 20462497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-20 as a target in psoriasis treatment.
    Stenderup K; Rosada C; Worsaae A; Clausen JT; Norman Dam T
    Ann N Y Acad Sci; 2007 Sep; 1110():368-81. PubMed ID: 17911452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression and production of interleukin 10 in human myeloma cell lines.
    Otsuki T; Yamada O; Yata K; Sakaguchi H; Kurebayashi J; Yawata Y; Ueki A
    Br J Haematol; 2000 Dec; 111(3):835-42. PubMed ID: 11122145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acinar cells of the pancreas are a target of interleukin-22.
    Aggarwal S; Xie MH; Maruoka M; Foster J; Gurney AL
    J Interferon Cytokine Res; 2001 Dec; 21(12):1047-53. PubMed ID: 11798462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A; Arai K
    Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-24 and its receptors.
    Wang M; Liang P
    Immunology; 2005 Feb; 114(2):166-70. PubMed ID: 15667561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin 20: discovery, receptor identification, and role in epidermal function.
    Blumberg H; Conklin D; Xu WF; Grossmann A; Brender T; Carollo S; Eagan M; Foster D; Haldeman BA; Hammond A; Haugen H; Jelinek L; Kelly JD; Madden K; Maurer MF; Parrish-Novak J; Prunkard D; Sexson S; Sprecher C; Waggie K; West J; Whitmore TE; Yao L; Kuechle MK; Dale BA; Chandrasekher YA
    Cell; 2001 Jan; 104(1):9-19. PubMed ID: 11163236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-10 in the brain.
    Strle K; Zhou JH; Shen WH; Broussard SR; Johnson RW; Freund GG; Dantzer R; Kelley KW
    Crit Rev Immunol; 2001; 21(5):427-49. PubMed ID: 11942558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.